semaglutide fitness news Ozempic users may be making a major weight-loss mistake, new study suggests Weight loss medications Ozempic and

SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes

If you have type 2 diabetes, Semaglutide might be a good option to discuss with your doctor

The numbers deserve specific attention because they inform expectations

Powered by neuropeptides, protein-like building blocks that visibly reduce wrinkles, sagging, dullness and discoloration, these high-performance products help visibly firm, lift and smooth fragile skin while improving the look of tone and texture